Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.945 USD | -0.88% | -3.19% | -84.12% |
May. 14 | Wolfe Research Downgrades RAPT Therapeutics to Peer Perform From Outperform | MT |
May. 10 | Guggenheim Downgrades RAPT Therapeutics to Neutral From Buy | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-84.12% | 138M | |
+16.73% | 123B | |
+13.04% | 107B | |
-5.80% | 24.01B | |
+2.21% | 22.59B | |
-10.09% | 18.16B | |
-40.52% | 16.84B | |
-14.00% | 16.23B | |
+1.18% | 13.43B | |
+24.18% | 11.32B |
- Stock Market
- Equities
- RAPT Stock
- News RAPT Therapeutics, Inc.
- Goldman Sachs Initiates RAPT Therapeutics at Buy With $27 Price Target